Skip to main content

Biotech ETFs Strengthen After Judge Blocks Trump’s Drug Pricing Rule

Biotechnology stocks and sector-related exchange traded funds stood out on Tuesday after a U.S. District Court overruled President Donald Trump’s wishes to require drugmakers list prices on television advertisements. Among the better performers on Tuesday, the SPDR S&P Biotech ETF...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.